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Background: In low- and middle-income settings, obtaining informed consent for biobanking may be com-
plicated by socio-economic vulnerability and context-specific power dynamics. We explored participants experi-
ences and perceptions of the research objectives in a community-basedmultidisease screening and biospecimen
collection platform in rural KwaZulu-Natal, South Africa.
Methods: We undertook semi-structured in-depth interviews to assess participant understanding of the in-
formed consent, research objectives and motivation for participation.
Results: Thirty-nine people participated (individuals who participated in screening/biospecimen collection and
those who did not andmembers of the research team). Some participants said they understood the information
shared with them. Some said they participated due to the perceived benefits of the reimbursement and conve-
nience of free healthcare. Most who did not participate said it was due to logistical rather than ethical concerns.
None of the participants recalled aspects of biobanking and genetics from the consent process.
Conclusions: Althoughmost people understood the study objectives, we observed challenges to identifying lan-
guage appropriate to explain biobanking and genetic testing to our target population. Engagementwith commu-
nities to adopt contextually relevant terminologies that participants can understand is crucial. Researchers need
to be mindful of the impact of communities’ socio-economic status and how compensation can be potentially
coercive.
Keywords: demographic surveillance, ethics, informed consent, South Africa.
Introduction
The concern that potential coercion could undermine the valid-
ity of informed consent is a key ethical challenge to clinical re-
search in lower- and middle-income countries (LMICs). Some re-
searchers have reported concerns of coercion due to unequal
power dynamics and socio-economic disadvantage.1–3 These
vulnerabilities have led to debates on the validity of the informed
consent process questioning the competence, comprehension
and voluntariness of research participants in these contexts.4,5
This is especially true of research with complex procedures and
involving innovative approaches such as genetics and biobank-
ing.6–8 Biobanking involves the collection of biological samples,
including blood, urine and other human body tissues and fluids.
© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. This is an Open Access
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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These approaches have the potential to transform health-
care, leading to precision medicine that involves knowing an
individual’s genomic traits, thus making it easier to guide disease
prevention, diagnosis and treatment.
However, more ethical dilemmas are introducedwith these in-
novative approaches, including how researchers explain themag-
nitude and international nature of data sharing that is part of
biobanking and how they guarantee the confidentiality and pro-
tection of participants when their biological samples are stored
for future research use.9 Biobanking is essential to support re-
search that will identify genetic and environmental factors con-
tributing to diseases in Africa and improve the health of the
African population. However, a question of whether research par-
ticipants understand the magnitude of their consent remains
unanswered.
Since 2000, the Africa Health Research Institute (AHRI) has
maintained a longitudinal population-based health and demo-
graphic surveillance system (HDSS) in rural KwaZulu-Natal, South
Africa, with optional human immunodeficiency virus (HIV) test-
ing added in 2003. The area is 854 km2 in size and includes a
population of approximately 90 000 residents (people who spend
most of their nights in the surveillance area) and 40 000 non-
residents (people who are part of the households but physically
spendmost of their nights outside the surveillance area) who are
members of approximately 20 000 households. In 2018, in re-
sponse to the epidemiological shift and an increased focus on
biomedical science, the AHRI established amultimorbidity cohort
and accompanying specimen biobank. Roving community-based
health camps for multidisease screening (HIV, tuberculosis, hy-
pertension and diabetes) and the collection of biosamples were
deployed throughout the HDSS.10 The goal of the programwas to
assess pathogen, host and environmental determinants of health
and disease, leading to the development of novel scientific and
public health interventions. The programme is known as Vukuzazi
(‘wake up and know ourselves’) in the local language (isiZulu). Ex-
plaining the Vukuzazi research objectives was an essential com-
ponent of engagementwith participants, thewider local research
community and stakeholders to ensure the ethical conduct of re-
search that met community needs.2,11,12
In this article we describe the contextually informed experi-
ences and perceptions of the research objectives by participants
in Vukuzazi.
Methods
Study setting
The studywas conducted in the uMkhanyakude district, KwaZulu-
Natal, which is the second most deprived district in South Africa,
with a high incidence and prevalence of HIV.13,14 In this predom-
inantly rural area, there are high levels of poverty and unemploy-
ment and the proportion of individuals with no formal education
is higher than that of the national population.13
Vukuzazi process of community engagement
The study was first presented and discussed with the AHRI Com-
munity Advisory Board (CAB) and other local stakeholders, in-
cluding elected and traditional leaders and the Department of
Health. Discussions included aspects such as the request for self-
administered rectal swabs, the process of collecting biological
samples and some limitations of AHRI, such as in cancer screen-
ing, which the community members were interested in. This was
followed by presentations through roadshows to the commu-
nity by the AHRI public engagement team. At these roadshows,
details of several AHRI projects were discussed, giving commu-
nity members the opportunity to ask questions and engage with
the institute’s research. At several key time points (after the pi-
lot, after enrolment of the first 1000 participants, after 6 and
12 months) the study team met with the CAB to give feedback
on the community’s experience of the study and to present pre-
liminary results.
Vukuzazi recruitment and informed consent process
Local isiZulu-speaking fieldworkers (individuals with a senior
school certificate [grade 12] and at least 2 years of experience
in a clinical research setting) visited eligible participants in their
homesteads to invite them to participate. During this visit, poten-
tial participants received a verbal explanation of the study and
a pictorial brochure in isiZulu that summarized the research ob-
jectives, activities, risks/benefits and reimbursement (see supple-
mentary material). Eligible participants were given at least 1 day
to read and consider the materials and decide whether to come
to the health camp. In homes with eligible minors (15–17 years
of age), the fieldworkers first engaged the parents/guardian and
upon obtaining parental/guardian approval, approached the mi-
nor with study materials and an invitation to attend the health
camp.
Upon arrival at the health camp, potential participants re-
ceived a 14-page written informed consent information sheet
in isiZulu that they could read while waiting (see supplementary
materials). Using an electronic system to document the process,
a clinical research assistant trained in Good Clinical Practice
conducted a private informed consent process using a script and
pictorial aids that had been refined based on participant and staff
feedback after the pilot phase. Participants had the opportunity
to ask questions and the professional nurses were also available
to respond to any queries. Consent was obtained from adult
participants and assent from minors whose parent/guardian
had provided consent. Prior to biosample collection, a study
nurse explained disease screening and referral algorithms and
reconfirmed consent to be screened for each condition and
receive clinical referrals based on their results. At this stage
participants could selectively withdraw their consent from any
particular study procedure without losing access to all other
study components. After their visit to the health camp, partici-
pants received their results by short message service (if normal)
or during a one-on-one home visit by a primary healthcare
nurse who explained their tests results, performed confirmatory
measurements or tests and made referrals to the public health
system for treatment.
Qualitative substudy sample
For this substudy, a random sample of participants and non-
participants was identified by the statistician using a computer
algorithm stratified by sex, age, participants, non-participants
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Table 1. Sample selection criteria
Gender Sample
Males Three non-participants
(one <24 y, one
24–50 y, one >50 y)
Three with either new
active TB or new HIV
(one <24 y, one
24–50 y, one >50 y)
Five with multimorbidity (i.e. with
two of either HIV, active or prior
TB, diabetes or hypertension) (one
<24 y, one 24–35 y, one 36–50 y,
two >50 y)
Four with no disease
(one <18 y, one
18–24 y, one
25–45 y, one >45 y)
Females Three non-participants
(one <24 y, one
24–50 y, one >50 y)
Three with either new
active TB or new HIV
(one <24 y, one
24–50 y, one >50 y)
Five with multimorbidity (i.e. with
two of either HIV, active or prior
TB, diabetes or hypertension) (one
<24 y, one 24–35 y, one 36–50 y,
two >50 y)
Four with no disease
(one <18 y, one
18–24 y, one
25–45 y, one >45 y)
and different states of health and disease. Staff members, rep-
resenting different positions in the team, were also sampled for
interview. Prior to conducting the interviews, the qualitative study
was explained and informed consent for audio-recorded inter-
views was obtained.
Qualitative substudy data collection
Semi-structured interviews were conducted by a social science
research assistant in the interviewee’s preferred language (isiZulu
or English) and location. The topic guide covered reasons for par-
ticipation or non-participation, the recruitment process, the inter-
viewee’s understanding and perception of study procedures (in-
cluding ethical aspects, especially informed consent and storage
and future use of biological samples). Staff members were asked
about their knowledge and understanding of participants’ under-
standing of the study and motivation to participate (see supple-
mentary material).
Qualitative substudy data management and analysis
The interviews were digitally recorded, audio files were tran-
scribed and those conducted in isiZulu were translated into En-
glish. All identifying information was removed from the interview
transcripts. The transcripts and emerging findings were reviewed
and discussed by the social science team. From these discussions,
a coding framework was developed based on the themes from
the topic guide and themes emerging from the data. The tran-
scripts were coded manually and analysed thematically.
Ethical approval
Ethical approval for Vukuzazi and the qualitative substudy was
obtained from the University of KwaZulu-Natal Biomedical Re-
search Ethics Board (BE560/17), the London School of Hygiene
and Tropical Medicine Ethics Committee (14722) and the Partners
Institutional Review Board (2018P001802).
Results
Thirty-nine individuals took part in the substudy: 31 invited par-
ticipants (24 participants, 7 non-participants) and 8 members of
the research team (representative of different study staff cadres:
fieldworker, driver, nurse, investigator). Table 1 shows the sam-
pling frame used to recruit.
Participant responses
Participant understanding of the informed consent
process
The majority of participants reported that they understood the
study procedures and had taken the time to read through the
information sheet, as reported by a 33-year-old man:
It was all in the paper they gave us, I took my time to read
and understand it. It was quite thick. It was asking us to con-
sent to participate and it was talking about how certain ill-
nesses are contracted and what not.
Participants with limited literacy indicated that verbal expla-
nations by the study staff allowed them tounderstand their rights
as a research participant despite their inability to read the written
materials, as described by a 54-year-old woman:
I understood that nothing was compulsory so if you didn’t
want to do something you could just say so. I signed with a
cross because I don’t know how to read.
Participants’ understanding of the research objectives
Most participants understood that Vukuzazi sought to determine
the patterns of health and disease in their community. For some
participants, understanding of this objective was difficult to fully
distinguish from the perceived healthcare delivery components
of the platform. A 22-year-old man said:
They explained. They said they want to see how the com-
munity is doing health-wise after five years. That’s what
they were doing. They want to see how healthy they will be.
Maybe someof those peoplewould have died after five years
if AHRI hadn’t come to help us. Some people found out they
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were sick, and they were linked to the treatment so they will
live for five years—I know a few of them.
Genetics and biobanking
When asked about biobanking and the genetic aspects of the
research, participants could not remember what they were told
during the informed consent process. After the researcher ex-
plained biobanking, some participants expressed positive views,
as a 28-year-old woman shared when asked about her feeling on
the storage of samples collected:
I don’t think there’s anything negative about it. I think it is
good because it will help us at the end of the day.
On the other hand, it seemed that others did not understand
biobanking or the process of storing samples and thought that it
was a bad idea, as this 24-year-old man shared:
It’s a bad idea. It must be stopped…No man, storing a hu-
man being’s blood in the fridge? Where have you ever seen
someone staying in a fridge? No, it’s a bad idea. Beer stays
in the fridge, not human blood.
Most participants said genetics and biobanking were complex
and therefore not easy to remember. A 28-year-old woman of-
fered advice when asked how we can improve knowledge about
genetics research in the community:
You can explain it by saying that the research looks at hered-
itary characteristics in your family and how they relate to
illness that one has or might be susceptible to. It’s not nec-
essarily that you got infected….Yes, the ‘hereditary’ concept
needs to be emphasised.
Reasons for participation: free convenient health check
Most participants stated that the main reason for their partici-
pation was the benefit of receiving a free health check and po-
tentially receiving healthcare services. The location of the mo-
bile health camp close to their homestead provided a convenient
means to access healthcare, as a 67-year-old woman stated:
I’ve always been someonewho likes going for regular check-
ups. I like knowing where I stand with all the many diseases
that exist nowadays. I like knowing what my situation is and
I figured it might be better to go to Vukuzazi because it had
located itself so close and convenient to us.
For some, the convenience and affordability of the service of-
fered at the health camp motivated them to participate; atten-
dance meant incurring no travel or medical costs with minimal
waiting time. A 36-year-old woman compared participation in
Vukuzazi with the costs she would incur if she had the same tests
in a health facility:
I was talking to a friend of mine about how expensive all the
things we were doing there [at the camp] are if you do them
with your own money or medical aid. Hospitals charge a lot
of money for those procedures.
Reasons for participation: loyalty to AHRI
Some participants indicated that they had been part of AHRI re-
search projects for a long time and therefore did not see any rea-
son not to continuewith their participation. A 75-year-oldwoman
explained:
[T]hey [AHRI] have been coming to us for a long time now.
So why would we stop taking part now when we have been
doing so for such a long time? Girls would visit us to sign us
up and we’ve had no problem, so it was the same thing this
time around.
A 41-year-old man said he wanted to continue supporting the
institute:
We have been supporting AHRI for a long time now, from
back when it was Africa Centre and my grandmother was
still alive. We are still supporting them now with Vukuzazi
and we will continue to do so.
Reasons for participation: reimbursement as an
incentive
Participants in Vukuzazi received reimbursement in the form of
a food voucher (100R [US$6]) and snack pack (water, apple,
biscuits), in accordance with South African National Health Re-
search Ethics Committee guidelines, which recommend consid-
eration of the participant’s time, inconvenience and expenses.15
Outside of the reimbursement calculation, participants also re-
ceived a Vukuzazi T-shirt that they changed into for the portable
chest X-ray procedure and then were allowed to keep. Some
participants appreciated the reimbursement, including the food,
they were given, which strengthened their loyalty to the AHRI. A
64-year-old man stated:
What I really likedmost is that AHRI gaveme food and R100
($6). I was able to send a child to go buy a few things for me.
This made me realise that there’s no way we could chase
AHRI away like we would do with before [in the past when
the Institute focused on HIV] because they are on our side
and they care about us so much that they can give us food.
Others shared how they thought some members of the com-
munity were not interested in the study objectives and wanted
the voucher or to receive something, as a 38-year-old woman
stated:
They just go there because they heard they will get some-
thing in return. Not because they genuinely want towake-up
and know themselves like the name of the study says.
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Reasons for non-participation
Some of the people contacted said that they were unable to par-
ticipate because they had other commitments at the time when
Vukuzazi was in their local area or because Vukuzazi operated pri-
marily during normal working hours, when they were at work.
I was working day shift that whole week, otherwise I
would’ve gladly taken part.— 23-year-old man
Oh, I was away because of work. They came here to invite
me but I was not home but they left my invitation with my
mom and she called me to tell me about it.— 52-year-old
man
However, some participants speculated about reasons that
their peersmay have chosen not to participate in the programme.
The rate of non-participation was highest among youngmen and
when asked about this a 22-year-oldmale participant suggested:
It is very hard for men to ask for or accept any sort of help.
With others it’s just a matter of ignorance, they aren’t very
clued up about a lot of things—health being one of them,
hence they don’t see the value in a project like Vukuzazi.
One person did not participate in Vukuzazi because he felt that
the AHRI kept taking information from the community without
giving back aid to address the poverty they were facing.
Research staff responses
Some research staff thought participants may have participated
because of the financial reimbursement and other benefits. The
staff said that such people had not appeared to be interested in
the explanation of the study being given during the informed con-
sent process. One staff member recalled:
There are people that you explain everything to, but you can
see that they aren’t really interested because they are just
there for the voucher. After taking blood samples we ask
people if they would like to receive their results and some
participants say ‘no, you can give me my diabetes results
but I would not like to receive my HIV results.’ So, you can
see that person isn’t really there for his health, it’s just the
voucher.
When it came to aspects of biospecimens and storage of sam-
ples, few participants seemed to understand the information
that had been given to them. One explanation for this could be
the way the recruiters may have described these concepts. As a
member of the research team explained:
What I can say about genetic testing is that we don’t tell
them toomuch about this. What we tell them is that there is
a blood sample thatwe are going to use to test their genetics
and they know that they won’t get the results of these tests
because the research is still under way. Some people don’t
really understand what genes are even when we explain it
to them.
Discussion
We found that most participants believed that they received
adequate information to decide on participating in the health
screening programme. However, others reported not under-
standing the content completely but signed the consent form
as an indication of voluntariness. It is possible that true vol-
untariness may have been compromised by some participants’
focus on the reimbursement or the perceived medical bene-
fits of participating. The latter may have led participants to not
fully comprehend the difference between Vukuzazi as a research
programme and as a healthcare service providing convenient
access to good quality care. This is consistent with previ-
ous empirical evidence indicating that research participants in
LMICs can have a high propensity to therapeutic misconcep-
tions and have an expectation of healthcare from research.16–19
It is not possible to ignore the socio-economic factors that
may promote research participation in situations of poverty
with limited access to resources and healthcare services.20,21
This vulnerability plays a role in voluntariness and the value
placed on reimbursements or access to healthcare that exceeds
local standards.22 Our results illustrate these challenges faced
by participants and the scientific community as they strive for
ethical inclusion of vulnerable populations into research stud-
ies.
The subject of participant reimbursement or compensation is
contentious in LMICs due to the potential undue influence it can
have on participants. Addressing this issue can be challenging
and engaging with the community through the CAB on under-
standing and developing a culturally sensitive method of com-
pensation is highly advised, as well as transparency by informing
participants whether they will be compensated or not and an ex-
planation of what the compensation is for. This will helpminimise
the perception of viewing this as a benefit andmaintain scientific
integrity.
We found that understanding of the concept of ‘future use’
of biosamples for genetic research was quite limited. Partici-
pants struggled to recall the genetics research information that
had been shared during the informed consent process, although
when the interviewer explained these concepts, most had pos-
itive views and thought biobanking was a good thing. The lack
of understanding of biobanking and genetic research is similar
to previous research in other settings where participants had dif-
ficulty in comprehending such concepts.23,24 This highlights the
need for strategies such as better explanations of these complex
concepts, working with communication professionals in develop-
ing material, cognitive testing to check comprehension and in-
volving native speakers with knowledge of the study area.25–28
One participant suggested focusing on terminology that is easily
understood by the community, such as ‘hereditary characteris-
tics’ in explaining genetics research. This is in line with previous
research and has been identified as a framework tenet for in-
formed consent of genetic research in Africa.8
This study highlighted how some forms of structural coer-
cion may exist whereby community members are loyal to a re-
search institute, which may influence power dynamics and vol-
untariness.29 Researchers need to anticipate these structural and
power issues that may be in play within such communities and
develop innovative ways of checking and ensuring that agree-
ment to participate is given freely.
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Despite these multiple barriers to comprehension and ethi-
cal challenges experienced, many participants affirmed that they
understood that the purpose of the researchwas to better under-
stand the nature of health and disease in the community. Even
though some of these interviews were conducted months after
participants engaged with the health camp, they recalled the ra-
tionale for some of the procedures and were able to share their
understanding. This indicated an enduring and internalized com-
prehension of at least some of the sophisticated research objec-
tives by most participants.
One strength of this study is that we were able to triangulate
data sources, which was helpful in shedding light and identifying
the potentialmismatch in information betweenwhat researchers
believe participants understood and what the participants them-
selves express. A limitation is that we failed to collect sufficient
data on participants’ understanding of the genetic and biobank-
ing aspects of the study. Our interviewer had difficulty engaging
participants about both these themes. While this could reflect
the complex nature of these concepts and terminologies used, it
might be reflective of the duration between the study and the in-
terviews or a failure to adequately explain these procedures dur-
ing the consenting process. As genomic and biobanking studies
are expanding in both scope and number, futurework should bet-
ter explore study participant understanding of these issues in hu-
man subjects’ research.7
Conclusions
The informed consent process in clinical research in LMICs is of-
ten challenging and requires careful preparation, especially in set-
tingswhere there has been a long history of research and inwhich
open-ended biobanking protocols are being introduced. It is pos-
sible that people take part in research and the procedures they
are asked to undertake on trust, because of the long-standing
relationship, without engaging with the purpose of new stud-
ies. In a context where there are high rates of unemployment,
poverty and low literacy, care is required to both ensure the pur-
pose of the research is explained clearly and any suggestion of
research procedures being misconstrued as a free health service
addressed. Our findings underline the importance of engagement
of the community to ensure that the research objectives serve the
needs of the community, engaging in thoughtful development of
consent forms that are appropriately targeted in language and
delivery method to the study population, following up with par-
ticipants to assess understanding and answer questions about
the research they take part in, and the importance of training re-
search staff to give time and care to the process of guiding a par-
ticipant through the informed consent process.
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